Clovis Oncology to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Company management will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Tuesday, May 15, 2012 at 8:00 AM Pacific Time. The conference will be held at the Encore at Wynn Las Vegas.
A live webcast of the presentation will be accessible through the investor relations section of the Companys website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Companys website for 30 days.
About Clovis Oncology (CLVS)
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.
Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
Breanna Burkart, 303-625-5023
Source: Clovis Oncology, Inc.Copyright Business Wire 2012